What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cardiology
- Surgery
Eric Boersma spends much of his time researching Internal medicine, Cardiology, Myocardial infarction, Surgery and Coronary artery disease.
His studies in Heart failure, Percutaneous coronary intervention, Angina, Hazard ratio and Heart disease are all subfields of Internal medicine research.
All of his Cardiology and Ejection fraction, Revascularization, Angioplasty, Cardiac resynchronization therapy and Dobutamine investigations are sub-components of the entire Cardiology study.
His research integrates issues of Odds ratio and Stroke in his study of Myocardial infarction.
Eric Boersma interconnects Incidence and Risk factor in the investigation of issues within Surgery.
As a part of the same scientific family, Eric Boersma mostly works in the field of Coronary artery disease, focusing on Radiology and, on occasion, Predictive value of tests and Coronary arteries.
His most cited work include:
- Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes (1706 citations)
- ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation (876 citations)
- Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. (826 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Cardiology, Myocardial infarction, Surgery and Coronary artery disease.
His work in the fields of Internal medicine, such as Heart failure, Percutaneous coronary intervention, Ejection fraction and Acute coronary syndrome, overlaps with other areas such as In patient.
His work in Heart failure addresses subjects such as Clinical endpoint, which are connected to disciplines such as Prospective cohort study.
Many of his studies on Cardiology apply to Hazard ratio as well.
His Myocardial infarction research includes elements of Odds ratio and Randomized controlled trial.
Eric Boersma combines subjects such as Intravascular ultrasound, Radiology and Artery with his study of Coronary artery disease.
He most often published in these fields:
- Internal medicine (75.14%)
- Cardiology (63.18%)
- Myocardial infarction (26.24%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (75.14%)
- Cardiology (63.18%)
- Heart failure (16.00%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Cardiology, Heart failure, Acute coronary syndrome and Clinical endpoint.
His work in Coronary artery disease, Biomarker, Hazard ratio, Myocardial infarction and Prospective cohort study are all subfields of Internal medicine research.
His research investigates the connection with Myocardial infarction and areas like Meta-analysis which intersect with concerns in MEDLINE.
Eric Boersma conducted interdisciplinary study in his works that combined Cardiology and In patient.
His study looks at the relationship between Heart failure and topics such as Interquartile range, which overlap with Troponin T.
In his study, Randomized controlled trial is inextricably linked to Physical therapy, which falls within the broad field of Acute coronary syndrome.
Between 2017 and 2021, his most popular works were:
- Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization (47 citations)
- Plasma concentrations of molecular lipid species predict long-term clinical outcome in coronary artery disease patients. (46 citations)
- Near-infrared spectroscopy-derived lipid core burden index predicts adverse cardiovascular outcome in patients with coronary artery disease during long-term follow-up (38 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Myocardial infarction
His main research concerns Internal medicine, Cardiology, Clinical endpoint, Heart failure and Coronary artery disease.
Internal medicine is represented through his Biomarker, Hazard ratio, Prospective cohort study, Myocardial infarction and Acute coronary syndrome research.
As part of his studies on Cardiology, Eric Boersma often connects relevant areas like Stroke.
His Clinical endpoint research incorporates themes from Red blood cell distribution width and Framingham Risk Score.
Eric Boersma works mostly in the field of Heart failure, limiting it down to topics relating to Outpatient clinic and, in certain cases, Heart disease, as a part of the same area of interest.
The Coronary artery disease study combines topics in areas such as Coronary arteries, Adverse effect, Oxidized ldl and Revascularization.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
